Related Experiment Video
Updated: Feb 1, 2026
08:43
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
7.8K
[Management of vestibular schwannomas]
Laryngo- Rhino- Otologie
|December 12, 2018
Summary
Vestibular schwannomas, tumors of the vestibulocochlear nerve, cause hearing loss and balance issues. Diagnosis involves audiological, vestibular, and imaging tests, with MRI as the gold standard for management decisions.
Area of Science:
- Neurosurgery
- Otolaryngology
- Oncology
Background:
- Vestibular schwannomas are benign neoplasms of the vestibulocochlear nerve's Schwann cells.
- They represent 6-7% of intracranial tumors and 90% of cerebellopontine angle tumors.
- Bilateral occurrence, seen in <5% of cases, is associated with type 2 neurofibromatosis.
Purpose of the Study:
- To review the diagnosis and management of vestibular schwannomas.
- To discuss the impact of these tumors on quality of life.
Main Methods:
- Audiological and vestibular assessments.
- Magnetic Resonance Imaging (MRI) for diagnosis and staging.
- Review of management strategies including observation, surgery, radiation, and drug therapies.
Main Results:
- Unilateral hearing loss is an early symptom, often followed by balance disorders, tinnitus, and facial paralysis.
- MRI is the gold standard for diagnosis.
- Management is individualized based on tumor size, patient age, and other factors.
Conclusions:
- Effective management requires a multidisciplinary approach considering tumor characteristics and patient factors.
- Rehabilitation options like cochlear implants can improve quality of life.
- Long-term care must address hearing impairment, balance disorders, tinnitus, and headaches.
Related Concept Videos
01:29The Vestibular System
43.9K
The vestibular system is a set of inner ear structures that provide a sense of balance and spatial orientation. This system is comprised of structures within the labyrinth of the inner ear, including the cochlea and two otolith organs—the utricle and saccule. The labyrinth also contains three semicircular canals—superior, posterior, and horizontal—that are oriented on different planes.
43.9K
01:26Tonsillitis II: Management
429
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
429
01:29Impression Management Techniques I: Managing Appearances
217
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
217
01:19Managing Impressions
172
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
172
01:19Management of Insomnia
638
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
638
01:24Cystic Fibrosis: Management
539
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
539